NASD · Healthcare · Medical Instruments & Supplies · USA
Medline Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Medline Inc is the largest provider of medical-surgical products and supply chain solutions serving healthcare facilities across all care settings. The company operates two segments: Medline Brand, offering surgical supplies and wound care products, and Supply Chain Solutions, distributing products from third-party suppliers. Medline serves customers through its Prime Vendor model and global distribution network.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Medline Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.
Leak Score: 33/100 on 6 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
24 more in this industry show a wider margin of safety.
We do not publish a verdict on MDLN yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.
We do not publish one (as of the 2026-10-19 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.
33 out of 100, which we rate "On Watch", on 6 of 12 value investing signals.